Vanguard Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.5M | Buy |
3,957,122
+58,687
| +2% | +$1.19M | ﹤0.01% | 1920 |
|
|
2025
Q1 | $70.8M | Buy |
3,898,435
+16,440
| +0.4% | +$298K | ﹤0.01% | 1945 |
|
|
2024
Q4 | $98.1M | Buy |
3,881,995
+12,213
| +0.3% | +$309K | ﹤0.01% | 1876 |
|
|
2024
Q3 | $132M | Buy |
3,869,782
+130,743
| +3% | +$4.44M | ﹤0.01% | 1749 |
|
|
2024
Q2 | $138M | Buy |
3,739,039
+88,457
| +2% | +$3.27M | ﹤0.01% | 1694 |
|
|
2024
Q1 | $153M | Buy |
3,650,582
+604,251
| +20% | +$25.4M | ﹤0.01% | 1661 |
|
|
2023
Q4 | $121M | Buy |
3,046,331
+427,827
| +16% | +$17M | ﹤0.01% | 1760 |
|
|
2023
Q3 | $72.1M | Buy |
2,618,504
+20,688
| +0.8% | +$569K | ﹤0.01% | 1966 |
|
|
2023
Q2 | $88.1M | Buy |
2,597,816
+49,218
| +2% | +$1.67M | ﹤0.01% | 1920 |
|
|
2023
Q1 | $91.7M | Buy |
2,548,598
+35,034
| +1% | +$1.26M | ﹤0.01% | 1869 |
|
|
2022
Q4 | $112M | Buy |
2,513,564
+38,183
| +2% | +$1.7M | ﹤0.01% | 1748 |
|
|
2022
Q3 | $69.6M | Buy |
2,475,381
+40,009
| +2% | +$1.12M | ﹤0.01% | 2008 |
|
|
2022
Q2 | $65.7M | Buy |
2,435,372
+1,777
| +0.1% | +$47.9K | ﹤0.01% | 2064 |
|
|
2022
Q1 | $82.9M | Buy |
2,433,595
+20,539
| +0.9% | +$700K | ﹤0.01% | 2052 |
|
|
2021
Q4 | $93.2M | Buy |
2,413,056
+136,857
| +6% | +$5.29M | ﹤0.01% | 2019 |
|
|
2021
Q3 | $123M | Buy |
2,276,199
+305,793
| +16% | +$16.5M | ﹤0.01% | 1868 |
|
|
2021
Q2 | $65.9M | Buy |
1,970,406
+172,079
| +10% | +$5.75M | ﹤0.01% | 2222 |
|
|
2021
Q1 | $37M | Buy |
1,798,327
+30,412
| +2% | +$626K | ﹤0.01% | 2470 |
|
|
2020
Q4 | $31M | Buy |
1,767,915
+44,598
| +3% | +$781K | ﹤0.01% | 2428 |
|
|
2020
Q3 | $25.6M | Buy |
1,723,317
+427,111
| +33% | +$6.33M | ﹤0.01% | 2333 |
|
|
2020
Q2 | $16.9M | Buy |
1,296,206
+758,278
| +141% | +$9.86M | ﹤0.01% | 2506 |
|
|
2020
Q1 | $893K | Buy |
537,928
+21,810
| +4% | +$36.2K | ﹤0.01% | 3518 |
|
|
2019
Q4 | $1.15M | Hold |
516,118
| – | – | ﹤0.01% | 3602 |
|
|
2019
Q3 | $1.1M | Buy |
516,118
+217,444
| +73% | +$463K | ﹤0.01% | 3627 |
|
|
2019
Q2 | $800K | Sell |
298,674
-189,562
| -39% | -$508K | ﹤0.01% | 3735 |
|
|
2019
Q1 | $2.4M | Sell |
488,236
-5,773,667
| -92% | -$28.4M | ﹤0.01% | 3388 |
|
|
2018
Q4 | $1.24M | Buy |
6,261,903
+214,339
| +4% | +$42.4K | ﹤0.01% | 3500 |
|
|
2018
Q3 | $2.73M | Buy |
6,047,564
+421,700
| +7% | +$190K | ﹤0.01% | 3432 |
|
|
2018
Q2 | $2.83M | Sell |
5,625,864
-382,121
| -6% | -$192K | ﹤0.01% | 3396 |
|
|
2018
Q1 | $14M | Sell |
6,007,985
-2,530,190
| -30% | -$5.9M | ﹤0.01% | 2649 |
|
|
2017
Q4 | $24.2M | Buy |
8,538,175
+866,586
| +11% | +$2.46M | ﹤0.01% | 2417 |
|
|
2017
Q3 | $21.9M | Sell |
7,671,589
-2,103,269
| -22% | -$6.02M | ﹤0.01% | 2453 |
|
|
2017
Q2 | $24.1M | Buy |
9,774,858
+708,095
| +8% | +$1.75M | ﹤0.01% | 2377 |
|
|
2017
Q1 | $32.7M | Buy |
9,066,763
+1,278,206
| +16% | +$4.61M | ﹤0.01% | 2192 |
|
|
2016
Q4 | $27.6M | Buy |
7,788,557
+300,673
| +4% | +$1.06M | ﹤0.01% | 2259 |
|
|
2016
Q3 | $30.3M | Buy |
7,487,884
+224,545
| +3% | +$907K | ﹤0.01% | 2171 |
|
|
2016
Q2 | $31.9M | Buy |
7,263,339
+492,102
| +7% | +$2.16M | ﹤0.01% | 2112 |
|
|
2016
Q1 | $25.6M | Sell |
6,771,237
-20,038
| -0.3% | -$75.7K | ﹤0.01% | 2183 |
|
|
2015
Q4 | $106M | Buy |
6,791,275
+218,742
| +3% | +$3.43M | 0.01% | 1423 |
|
|
2015
Q3 | $69.3M | Buy |
6,572,533
+213,787
| +3% | +$2.25M | 0.01% | 1692 |
|
|
2015
Q2 | $160M | Buy |
6,358,746
+268,152
| +4% | +$6.76M | 0.01% | 1213 |
|
|
2015
Q1 | $170M | Buy |
6,090,594
+685,241
| +13% | +$19.1M | 0.01% | 1126 |
|
|
2014
Q4 | $98.6M | Buy |
5,405,353
+203,418
| +4% | +$3.71M | 0.01% | 1425 |
|
|
2014
Q3 | $67.4M | Buy |
5,201,935
+22,366
| +0.4% | +$290K | 0.01% | 1629 |
|
|
2014
Q2 | $84.5M | Buy |
5,179,569
+96,475
| +2% | +$1.57M | 0.01% | 1512 |
|
|
2014
Q1 | $89.8M | Buy |
5,083,094
+110,819
| +2% | +$1.96M | 0.01% | 1420 |
|
|
2013
Q4 | $120M | Buy |
4,972,275
+1,152,977
| +30% | +$27.9M | 0.01% | 1198 |
|
|
2013
Q3 | $135M | Buy |
3,819,298
+1,301,392
| +52% | +$46.1M | 0.01% | 1052 |
|
|
2013
Q2 | $39.3M | Buy |
+2,517,906
| New | +$39.3M | ﹤0.01% | 1778 |
|